Saturday, October 20, 2007

Risk-reduced cost management practices (No. 2)

2. Risk-free clinical trials

Taking the risk out of the clinical trials has been tried successfully by companies like Avalon by developing a fully-integrated technology platform called AvalonRx in partnerships with Merck, MedImmune, ChemDiv, Medarex, and Novartis which utilize a proprietary drug discovery and development platform. It is based on large-scale biomarker identification and monitoring, to discover and develop therapeutics for pathways that have historically been characterized as "undruggable”. Using biomarker’s biochemical features or facets to measure the progress of a disease or the effects of treatment as applied in DNA Sequencing and fragment analysis. Biomarkers can be used to assist clinicians in disease assessment or researchers in their discovery efforts, thus reducing the cost of conducting clinical trials.

No comments:

Post a Comment